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1. Introduction 
The thyroid gland is one of the largest endocrine glands. It is prone to several very distinct 
pathologies, some of which are extremely common such as autoimmune thyroid diseases 
(AITDs). AITDs are conditions in which the immune system attacks the body’s own thyroid 
gland which leads to a deregulation in thyroid hormones production. Because these hormones 
are used almost everywhere in the body, AITDs can have widespread, serious effects and 
many symptoms. AITDs can be broken down into two classes: i- Graves' disease (GD) 
characterized by hyperthyroidism and ii-Autoimmune Hypothyroidism, where the major 
clinical form is Hashimoto’s thyroiditis (HT). In HT, the antibodies against thyroid peroxidase 
or thyroglobulin appear characteristically in the patients' sera, while tissue damage due to 
T cell-mediated cytotoxicity usually contributes to gradual development of hypothyroidism.  
HT, described by Hakaru Hashimoto in 1912, is a common autoimmune disease, afflicting 
up to 10% of the population (Canaries et al., 2000). However, its etiology is still unknown. In 
fact, although environmental factors, such as infection, certain drugs, stress, smoking, can 
play a role in their progression, the HT- as AITDs - is generally hereditary in origin. 
Comprehension of physiopathological mechanism behind has been improved over the last 
few decades. In the literature, a number of excellent reviews have been published on the 
genetic background of AITDs (Eschler et al., 2011; Hadj Kacem et al., 2009). However, there 
is still a paucity concerning HT. Several parameters have contributed to this paucity. Some 
of them are general for AITDs such as genetic heterogeneity; others are rather specific to HT 
mainly clinical heterogeneity and diagnostic difficulties. This chapter examines the recent 
progress in our understanding of the genetic and environmental contributions to the 
etiology of Hashimoto's thyroiditis. We will also focus on epidemiology, clinical progression 
and physiopathological mechanism of the disease. We will shed light on our findings 
concerning a Tunisian multigenerational family “Akr” (Maalej et al., 2001a) which has 
benefited from a regular clinical follow-up, a complex segregation analysis as well as a 
genetic investigation using both genome screening and candidate genes approaches.  
2. Epidemiology 
Hashimoto's thyroiditis is a common form of chronic AITDs. The disorder affects from 2% 
(Wang et al., 1997) up to 10% (Canaries et al., 2000) of the general population.  It is more 
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common in older women and ten times more frequent in women than in men (Tunbridge et 
al., 2000). Based on TSH (thyroid stimulating hormone) levels or anti-thyroid auto 
antibodies, a population-based prevalence study has reported prevalence of 3.6% and 8.8% 
respectively (Tunbridge et al., 1977). In the United States, Hollowell and collaborators (2002) 
found that 4.6% of the population had hypothyroidism and 13.0% had anti-thyroid 
peroxydase auto antibodies. 
In Tunisian population, a study performed on 1076 patients who resorted to the Department 
of Endocrinology of Sfax, Hédi Chaker Universitary Hospital at Sfax, found that prevalence 
of HT was 22.8% (Chabchoub et al., 2006). This high value could be explained by the fact 
that this study has assed sedan oriented demand. In a district from the central east of 
Tunisia, where “Akr” family members live, the prevalence and incidence of AITDs were 
4.36% and 7.2 per 1000 inhabitants per year respectively. Particularly, the prevalence of 
autoimmune hypothyroidism was 2.13% (Bougacha-Elleuch et al., 2011). 
3. Etiology 
HT results from a complex combination of genetic, environmental, and endogenous factors 
which interplay to initiate thyroid autoimmunity.   
3.1 Environmental factors 
Several environmental factors are thought to affect the incidence and the progression of HT 
disease. Thus, recent studies have shown the close relationship between either excessive 
iodine levels (Camargo et al., 2006; Doğan et al., 2011; Teng et al., 2011) or Selenium 
deficiency (Toulis et al., 2010) and HT. High levels of several chemical agents have also been 
implicated in the incidence of goiter and autoimmune thyroiditis (de Freitas et al., 2010). 
Moreover, the components of several viruses (hepatitis C, human parvovirus B19, coxsackie 
and herpes viruses) were detected in the thyroid of Hashimoto's thyroiditis patients (Mori  
& Yoshida  2010). Moreover, the possible involvement of the oxidative stress profile in HT 
pathogenesis was also reported (Baskol et al., 2007; Lassouad et al., 2010).  
3.2 Epigenetic factors 
Using disease discordant twin pairs, Brix and collaborators have found that the frequency of 
skewed X chromosome inactivation in female twins with HT was 31% (vs 8% in control 
population) (Brix et al., 2005). In Tunisian population, findings reported by our team suggest 
a possible role for X chromosome inactivation mosaicism in the pathogenesis of AITDs (GD  
and HT) and may, to some extent, explain the female preponderance of these diseases 
(Chabchoub et al., 2009). 
3.3 Endogenous factors 
HT could be considered as a "sex realated disease", since women are more susceptible to 
develop HT than men. Indeed, the Sex ratio is 7F/1M (Duron et al., 2004), with an incidence 
of 3,5 cases per 1000 woman in year vs 0,8 cases per 1000 men per year (vanderpump et 
al.,1995). The importance of pregnancy and postpartum thyroiditis in autoimmune 
thyroiditis is well-established (Friedrich et al., 2008). 
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3.4 Genetic susceptibility to HT 
Evidence for genetic susceptibility to HT is strongly shown by epidemiological data from 
family and twin studies. 
3.4.1 Family studies 
The familial occurrence of AITDs (HT and GD) has been reported by investigators for many 
years (Hall & Stanbury, 1967; Martin, 1945). One of the large multiplex families in the world 
was reported in Tunisia (Akr family) (Maalej, A. et al. 2001a). The high prevalence of both 
GD and HT, found in the "Akr" family (17.5%), is another argument to the contribution of 
genetic factors in HT pathogenesis.  
3.4.2 Sibling risk ratio (λs) 
The λs is a useful quantitative measure of the heritability of a disease, with a λs greater than 
5 usually indicating a genetic influence on the etiology of the disease (Risch, 1990; Vyse & 
Todd, 1996). The risk in siblings of parents with AITDs was estimated to 28.0 for HT, giving 
evidence for a strong genetic component (Villanueva et al., 2003).  
3.4.3 Twin studies  
The use of twins is a well-established method to investigate the relative importance of 
genetic and environmental factors to traits and diseases (MacGregor et al., 2000). Thus, for 
HT, the concordance rates were 55 and 0% for Monozygotic and Dizygotic twins, 
respectively (Brix et al., 2000). Concerning anti thyroid antibodies, monozygotic twins had 
80% concordance, and dizygotic twins had only 40% concordance (Brix et al., 2000).  
4. Physiopathology  
It is well known that HT results from a multistep process, requiring several genetic and 
environmental abnormalities to converge before disease development. Thus, thyroid follicle 
damage may be provoked by self-antigen presentation by antigen presenting cells and 
specific T lymphocyte activation. On the other hand, toxic destruction of thyroid cells 
possibly through the generation of oxygen radicals may participate in eclosion of 
autoimmunity (Bagchi et al., 1995). Both proliferation and apoptosis are involved in the 
pathogenesis of HT. Analysis of the mechanisms by which such autoimmune pathology 
arises has been facilitated by the use of animal models. These include the   Obese Strain (OS) 
chicken and the BioBreeding (BB) and Buffalo rats as spontaneous models of HT. HT can 
also be experimentally induced by specific immunization protocols with target auto 
antigens or elevation of dietary iodine. 
4.1 Autoimmunity in HT 
HT is considered to be a th1-mediated disease leading to aberrant infiltration of lymphoid 
cells and destruction of thyroid follicles (figure1). The final outcome is fibrosis replacing 
normal thyroid parenchyma and hypothyroidism resulting of thyroid cell destruction 
(Parish & Cooke, 2004). Indeed, a central phase of HT is characterized by an apparent 
uncontrolled production of auto reactive CD4+ T cells, CD8+ cytotoxic T cells and 
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immunoglobulin G auto antibodies. This immunological synapse is defined by the interface 
between antigen presenting cells and T-cells that is formed during T-cell activation 
(Chistiakov, 2005). On the other hand, existence of naturally existing CD4+ CD25+ foxp3+ T 
regulatory cells influencing thyroiditis development in naïve susceptible mice was recently 
demonstrated. Moreover, it has been shown that naturally T regulatory cells are required for 
induction of antigen specific tolerance, indicating that induced Murine experimental 
autoimmune thyroiditis tolerance is a result of activation of naturally existing T regulatory 
cells rather than de novo generation of induced T regulatory cells ( Morris et al., 2009). 
Interestingly, several of the AITDs susceptibility genes participate in the immunological 
synapse, suggesting that abnormalities in antigen presentation are important mechanisms 
leading to AITDs (Tomer, 2010). 
Initially, the production of self-reactive cells and auto antibodies occurs in the draining lymph 
nodes. Later, the lymphoid tissue often develops directly in the thyroid gland itself. This tissue 
is generally very well-organized, with cords of anti-Tg-antibody- producing plasma cells in the 
periphery (Chistiakov, 2005). In a final, destructive step of HT, the auto reactive T cells 
diffusely accumulate in large numbers and infiltrate thyroid parenchyma. This phenomenon 
will determine clinical phenotype of the disease. In the BB-DP rat model, Th1-mediated 
mechanisms involving production of IL-12, tumor necrosis factor-ǂ (TNF-ǂ) and interferon-Ǆ 
play a major role in the destruction of thyrocytes (Blüher et al., 1999a; Mooij et al., 1993). 
Furthermore, it has been recently shown that pro-IL18 is constitutively expressed in thyroid 
cells and IL18 up regulation by INF-Ǆ is an immunological feature of HT patients with an 
important role in promoting the local immune response (Liu et al., 2010). 
4.2 Apoptosis in HT  
Apoptosis appears to play a major role in the final stage of the disease (figure1). In fact, 
apoptotic molecules such as Fas and Fas ligand (FasL) expression was higher in rats with 
lympholytic thyroiditis indicating a possible role in thyrocyte death (Blüher et al., 1999b). 
Theses molecules are expressed at low level by normal thyroid cells compared to patients with 
HT with an increasing number of apoptotic cells (Kaczmarek et al., 2011). The mechanism and 
regulation of apoptosis in thyroid gland are still little known.  The most studied receptor 
mediated apoptic pathway is the Fas/Fas ligand system. Fas is substantially expressed on 
lymphocytes. Fas-Fas ligand interaction could lead to the thyrocyte cell death (Kaczmarek et 
al., 2011). Thyroid cells express constitutively Fas but these latters are normally unaffected by 
Fas-mediated apoptosis. In contrast, they can be sensitised to Fas-induced destruction under 
certain pathologic conditions such as the release of IFN-Ǆ, TNF-ǂ and IL-1ǃ, by infiltrating 
immune cells (Giordano et al., 2001).  Over the past few years, many reports have shown that 
mobilisation of the Fas/Fas ligand apoptotic pathway by proinflamatory cytokines plays a 
pivotal role in the devastation of thyroid follicular cells in HT leading to hypothyroidism. 
(Kaczmarek et al.,2011). Therefore, the Fas pathway is the most important mechanism of 
Tlymphocyte mediated apoptosis. It is just possible that this process plays an essential role in 
the pathogenesis of Hashimoto thyroiditis, because cytotoxic T lymphocytes are fully present 
in the thyroid in places where apoptosis is located (Mitsiades et al ., 1998 ; Fountoulakis et al., 
2008; Chen el al ., 2004; Baker., 1999; Bretz.,2002). 
Mechanisms of regulation of this pathway include probably changes in Fas expression level, 
and the expression of molecules that promote survival, including the Bcl-2 gene family 
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(Bretz et al.,1999; Mitsiades et al.,1998). This latter antiapoptotic protein and sFas system, 
which normally protect thyroid cells from apoptosis, are decreased in the thyroid cells of 
patients with HT, creating a proapoptotic phenotype (Fountoulakis & Tsatsoulis, 2004). 
Thus, the rate of thyrocyte apoptosis dictates the clinical outcome of thyroid autoimmunity. 
Though rare in normal thyroid, it markedly increases during HT, but not in GD with a 
divergent phenotype. Therefore, regulation of thyrocyte survival is a crucial pathogenic 
determinant via the balance between Th2 and Th1 response (Chistiakov, 2005).  
Despite the "crucial" role played by these apoptotic molecules, they are poorly investigated 
in HT pathogenesis at the genetic level. Therefore, arguments of their "real" implication in 
HT are still missing. 
 
Fig. 1. Autoimmune events in Hashimoto's thyroiditis. 
At the onset of disease, (HLA) class II-positive Antigen-presenting cells (APC), present 
thyroid-specific autoantigens to the naïve T cells, leading to the maturation of autoreactive  
T cells. Interaction with auto antigen leads to the production of different cytokines inducing 
T-helper type 1 (Th1)-mediated cell immune response. The stimulation of the Fas/Fas ligand 
apoptotic pathway by pro-inflammatory cytokines is the most important mechanism of 
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T lymphocyte mediated apoptosis. The caspase cascade ultimately induces enzymes that 
progressively destroy the cell, leading to thyroid cell death and hypothyroidism 
5. Clinical data 
HT occurs especially during the decades from 30 to 50 but no age is exempt, although the 
prevalence increases with age (Akamizu et al.,2008) The Sex ratio is 7F/1M, (Duron et 
al.,2004), with an incidence of 3.5 cases per 1000 women per year vs 0.8 cases per 1000 men 
per year (Vanderpump et al.,1995). 
This disease is primarily associated with symptoms of altered thyroid function. Early in the 
course of the disease, the patient is usually euthyroid, but may show clinical hyperthyroidism, 
due to the inflammatory breakdown of thyroid follicles with release of thyroid hormones. 
Thyrotoxicosis may be present in 20% of patients when first seen (Akamizu et al.,2008),or 
commonly develop over a period of several years. In contrast, late in the disease, the patient is 
often hypothyroid because of progressive destruction of the thyroid gland. The most common 
eventual outcome of HT is hypothyroidism (Bottazzo & Doniach 1986).  
In HT, the association of goiter with hypothyroidism is the most frequent condition of the 
diagnosis. Most often the gland is hypertrophic; two to four times the normal size, firm and 
nubbey. It is usually symmetrical, although much variation in symmetry can occur (Duron 
et al.,2004). Ultrasound may display an enlarged gland with normal texture, a characteristic 
picture with very low echogenity, or a suggestion of multiple well-defined nodules 
(Pedersen et al., 2000). 
The goiter of HT may remain unchanged for decades (Akamizu et al., 2008), but usually it 
gradually increases in size. However, in some cases there is an involution of the goiter with 
evolution. Hence, the two major forms of the disorder are goitrous and atrophic 
autoimmune thyroiditis. A fast increase of the volume of the goiter and a very firm 
consistence of a fibrous goiter in aging patients, have to be taken with particular attention 
due to possible existence of a malignancy or a thyroid lymphoma (Duron et al., 2004). 
Generally the progression from euthyroidism to hypothyroidism has been considered an 
irreversible process due to thyroid cell damage and loss of thyroidal iodine stores. However, 
it is now clear that up to one-fourth of patients who are hypothyroid may spontaneously 
return to normal function over the course of several years. This sequence may reflect the 
initial effect of high titers of thyroid stimulation blocking antibodies which fall with time 
and allow thyroid function to return (Takasu et al., 1992). Progression from subclinical 
hypothyroidism (normal FT4 but elevated TSH) to overt hypothyroidism occurs in a certain 
fraction (3-5%) each year. In Akr family, 11 patients (30%) had subclinical hypothyroidism 
(unpublished results). 
Various auto antibodies may be present in sera of patients with HT: anti-thyroid peroxidase 
antibodies and, less frequently, anti-thyroglobulin antibodies. These later are positive in about 
80% of patients and their prevalence increases with age. Anti- thyroid peroxidase antibodies 
are positive in 90% of patients; their frequency is higher in women and aging subjects. If both 
anti-thyroglobulin and anti-thyroid peroxidase antibodies are measured, 97% are positive. In 
contrast to the anti-thyroglobulin antibodies, the presence of anti-thyroid peroxidase antibody 
is correlated with the occurrence of hypothyroidism (duron et al.,2004).  
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The titles of anti -thyroid peroxidase antibodies are typically higher in atrophic form than in 
goitrous one.Young patients tend to have lower or occasionally negative levels. In this age 
group, even low titles evolve the presence of thyroid autoimmunity (Akamizu et al., 2008). 
In the Tunisian study achieved by our group, 70 patients belonging to "Akr" famiy, were 
included. This family is actually composed of about 400 members with high level of 
consanguinity (60.5% vs 38.3% in controls from the same region) (Bougacha-Elleuch et al., 
2011). Among these patients, 63 have benefited from a regular clinical follow up during 
these two last decades. Strikingly, we have found in this large family a co segregation of the 
two AITDs: 38 cases of HT (60.3%) and 25 cases (39.6%) of GD. Given the genetic 
predisposition of AITDs in this large family and occurrence of HT precisely at later ages, 115 
healthy members of “Akr” family were carefully followed up by physicians,  during 2 
decades. We have found that 13 subjects (11,3%) developed AITDs. HT was seen in 77% of 
the cases while GD was found in only 23% (Charfi et al., 2009). In these patients, HT was in a 
hyperthyroid state in 13. 6% vs only 5% in literature (Duron et al., 2004) 
6. Genetic susceptibility to HT  
In complex diseases such as HT, it's well-established now that genetic susceptibility exists 
and represents an important piece in the general puzzle. However, determining both the 
"true" involved genes and the importance of contribution of each gene in the 
physiopathology of the disease, remains a laborious task which is not achieved yet. 
To dissect the genetic component of HT, the major technologies used were mainly candidate 
gene analysis and whole-genome linkage screening. However, and unlike GD, at the genetic 
level, HT was poorly investigated as an individualized clinical entity. A general 
methodological problem has been disease definition. Indeed, HT encompasses a spectrum of 
manifestations, ranging from the simple presence of thyroid auto antibodies to the presence 
of goitrous or atrophic thyroiditis, characterized by gross thyroid failure (Davies et al., 
1993). A second problem is lack of families composed only of HT patients. Thus,  in most 
studies, AITDs are explored as a whole and in a second step, HT is considered aside. This 
situation is well encountered in genome scans where the investigated families usually 
comprise both GD and HT patients. This approach may identify more easily the common 
than the specific HT or GD gene susceptibility.  
Another issue in genetic investigation of complex diseases such as HT, is search of a major 
gene in the general genetic entity. Possible existence of such a major gene could be 
evidenced by a particular type of statistical analysis: ie complex segregation analysis. 
In our previous work, we have analyzed genetic susceptibility of AITDs (HT and GD) at the 
two levels: i-determination of involved genes using the two complementary approaches: ie 
whole genome screening and candidate genes analysis and ii- complex segregation analysis to 
search for possible major genes. In the following sections, we will focus on our findings 
concerning HT. 
6.1 Dissection of genetic susceptibility 
6.1.1 Whole genome screening 
Genome-wide linkage analysis was the first approach employed to screen the genome for 
the genetic contribution to AITDs and particularly HT. Thus, the first genome linkage scan 
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in AITDs was performed in 1999. There were two areas of linkage to HT, designated HT-1 
and HT-2 on chromosome 13q32 and 12q22, respectively (Tomer et al., 1999). Since, many 
genome screenings were conducted and revealed regions with suggestive linkage 
(MLS<3.3), except the chromosomal region 8q23-q24 which has given a value of MLS=3.77 
(Reviewed in Hadj Kacem et al., 2009). Therefore, it could be considered as "significantly 
linked" to HT.  Indeed, according to Lander and Kruglyak, in complex diseases (such as HT) 
a lod score of >1.9 is suggestive of linkage, while a lod score of >3.3 indicates significant 
linkage in studies using the parametric approach. Linkage is confirmed if evidence for 
linkage is replicated in two separate data sets (Lander & Kruglyak, 1995). 
Among linked regions, only 12q22 and 8q23-q24 were replicated. If we examine these 
replications, we will find that for the first region (12q22), we could not consider that 
replication was done in two separate data sets, since the second data set already contains the 
first one (Tomer et al., 2003; 2007). Concerning the second region (8q23-q24), replication was 
rather reported with AITDs and not HT (Tomer et al., 2002). In Tunisian population, 
genome screening, performed on Akr family, has revealed a genetic linkage of AITDs as a 
whole with the chromosomal region 2p.21. There were no regions linked to HT (Maalej et 
al., 2001a). 
6.1.2 Candidate genes  
Candidate genes analyzed in HT can be classified into two groups: (i) immune regulatory 
genes (MHC, CTLA-4, PTPN-22, cytokines..) and (ii) thyroid-specific genes (Tg, TPO, PDS..). 
Investigation of these genes in HT pathogenesis was done (for most of them) since they are 
functional candidates (they are selected by virtue of their physiological functions as possible 
contributors to disease pathogenesis). Among these genes, there are only two (CTLA-4 and 
Tg genes) which are both functional and positional genes (Table 1). In fact, they are localized 
in chromosomal regions found linked using the genome scan approach (2q33 and 8q23 
respectively). At the statistical level, these two regions share a significant value of lod score 
(MLS= 4.2 and 3.77 for 2q33 and 8q23 respectively) (reviewed in Hadj Kacem et al., 2009).We 
have to get in mind that the chromosomal region 2q33 (harboring CTLA-4 gene) was linked 
with positive antibody rather than HT.  
On the other hand, what we can note is that genetic associations reported with candidate 
genes were less definitive than in GD. Indeed, genetic investigation of AITDs since early 
1990, has given arise to “significantly associated genes” either with AITDs or GD, but not 
HT. This could be explained by limited investigated samples. Thus, until now, there is no 
consortium in HT. 
In table 1, we have only reported candidate genes which have been associated with HT 
and for which, potential mechanisms were proposed. In this regard, genes showing no 
association were not included. Potential mechanisms of associated genes variants were 
proposed by authors. They mainly involve higher production of either anti-thyroid 
antibody or the protein encoded by the gene itself. What we can note is that explored 
candidate genes are mainly those of immunoregulatory pathway. However, genes 
involved in apoptosis are poorly studied in HT in spite of their functional involvement in 
thyroid destruction in HT.  
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*: Candidate genes harbored in linked regions found by genome scans. 
**: The studied sample in Tunisian population is "Akr" family 
Table 1. Functional and positional candidate genes associated with HT pathogenesis. 
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6.1.2.1 Immune regulatory genes 
6.1.2.1.1 HLA 
Data on HLA haplotypes in HT have been less definitive than in GD. In patients with HT, 
HLA associations have been found with the HLA‘DR4’ haplotypes (Tandon et al., 1991). 
Interestingly, it was shown that substitution of the neutral amino acids Ala or Gln with 
arginine at position beta 74 in the HLA-DR peptide-binding pocket is a key to the etiology of 
both GD and HT (Ban et al., 2004; Menconi et al., 2008). 
In the Tunisian "Akr" family, using transmission disequilibrium test, we have reported a 
genetic association of AITDs with HLA-B37and HLA-DR11 alleles (Elleuch-Bougacha et al., 
2001). Sequencing of the rare allele HLA-B37 in Akr family, has given evidence that it is not 
a new variant, but rather the known subtype HLA-B37*01 (unpublished results). In a second 
step, investigation of MHC (class I, II and III) genes polymorphisms has shown that TNF-
308 A/G polymorphism was involved in GD and HT with different alleles.  
Thus, TNFA allele was associated with GD, whereas TNFG, HLA-DR11 and DR12 were 
rather implicated in HT pathogenesis giving evidence for particular component for each 
disease (GD or HT) (Bougacha-Elleuch et al., 2004). 
6.1.2.1.2 CTLA-4 gene 
CTLA-4 (cytotoxic T lymphocyte-associated 4) is a cell surface immunoglobulin like receptor 
involved in the regulation of T-lymphocyte activation. CTLA-4 gene polymorphisms have 
been shown to be associated with a variety of autoimmune conditions. The most consistent 
reported association was with AITDs (Taylor et al., 2006). A recent investigation of patients 
with HT provided evidence that -318C/T promoter, 49A/G exon 1 and CT60 CTLA-4 gene 
SNPs were associated with higher thyroid autoantibody concentrations (Zaletel et al., 2006; 
2010). In "Akr" family, CTLA-4 gene did not reveal any associated variant with HT (Maalej 
et al., 2001b). 
6.1.2.1.3 PTPN22 gene 
The PTPN22 (protein tyrosine phosphatase N22) molecule is involved in the activation of 
both naïve and activated T cells. The association of PTPN22 1858C/T polymorphism with 
HT is much weaker than the association with GD (Kahles et al., 2005). T-allele carriers were 
reported to be at particularly high risk of developing HT (Dultz et al., 2009). In a recent 
study performed in Japanese population, a novel protective effect of a haplotype containing 
five SNPs in this gene was observed for HT (Ban et al., 2010). 
In Akr family, stratifying patients according to their phenotype (HT) did not show any 
significant association with PTPN22 R620W allele (Chabchoub et al., 2006). 
6.1.2.1.4 VDR gene 
VDR (vitamin D receptor) plays an immunoregulatory role based on the fact that the 
activation of human leucocytes causes the expression of VDR. The VDR gene, lies on 
chromosome 12q12-14 and harbors several polymorphisms and was found to be associated 
with several autoimmune diseases, (Huang et al., 2002; Mc Dermott  et al., 1997; Pani et al., 
2000; 2002) 
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Our previous results, in Tunisian population, showed no significant association of the 
Vitamin D receptor gene polymorphisms with HT in the "Akr" family (Maalej et al. 2008). 
6.1.2.1.5 Cytokine genes  
Local release of cytokines within the thyroid gland is important in regulating antigen 
presentation and lymphocyte trafficking by enhancing the expression of MHC class II and 
adhesion molecules on thyroid follicular cells (Kelso, 1998) 
Studies, interested in cytokine gene polymorphisms with HT, are limited in literature. Thus, 
Ito C and collaborators (2006), have reported that the +874A/T polymorphism in the IFN-
gamma gene was associated with severity of HT. Moreover, a significant association 
between high IFN-gamma-producing genotype TT (+874 A/T) and HT was found (Rekha et 
al., 2006). A recent  study, exploring IL-1B, IL-1RN, IL-6 and TNFA genes polymorphisms, 
has given evidence that only IL-6 gene promoter (-572) C/G polymorphism could represent 
a potential "candidate" genetic marker to predict an individual's susceptibility to HT (Chen  
et al., 2006). It has been later revealed that the IL6-572G allele carriers, which have higher 
producibility of IL-6, were more frequent in severe HT (Inoue et al., 2011). Concerning IL4 
gene, it was shown that the-590CC genotype appears to be a strong predictive factor for the 
development of hypothyroidism in HT (Nanba  et al., 2008).  
In "Akr" family, investigation of IL-1RN VNTR, IL-1B-511 C/T and IL-1A-889 C/T SNPs in 
the IL1 gene cluster and TNFRI ((GT)17 (GA)n microsatellite marker has not revealed any 
association with HT (Kammoun-Krichen et al., 2007; 2008).  
6.1.2.2 IDDM6 locus 
The IDDM6 locus (on 18q21 chromosome) was found to be linked to many autoimmune 
diseases: (Davies et al., 1994), (Cornelis et al., 1998), (Shai et al., 1999) (Vaidya et al., 2000), 
providing evidence that it is likely to harbor important autoimmunity loci. This locus was 
also examined in "Akr" family. Genetic linkage was found associated with both AITDs and 
HT (Hadj kacem et al., 2006) confirming again its key role in autoimmunity.  
6.1.2.3 Thyroid specific genes 
6.1.2.3.1 Thyroglobulin gene 
Genetic-linkage studies have reported chromosome 8q24, containing the thyroglobulin  (Tg) 
gene, as a susceptibility locus for AITDs in two different family samples (Sakai et al. 2001; 
Tomer et al., 2002). Later, association of the thyroglobulin intragenic marker (Tgms2) was 
found with HT (Ban et al., 2004).  In a previous study, our group has examined the genomic 
region (11.5 cM) containing the Thyroglobulin gene by genotyping seven microsatellite 
markers and four SNPs in "Akr" family. Analysis of data did not show linkage of the 
Thyroglobulin gene with AITDs nor did analysis of HT and considered separately (Belguith-
Maalej et al. 2008). 
6.1.2.3.2 PDS gene 
The PDS gene (7q31), responsible for Pendred syndrome (congenital sensorineural hearing loss 
and goiter), encodes a transmembrane protein known as pendrin (Everett et al., 1997). Pendrin 
functions as a transporter of iodide and chloride (Scott et al., 1999). In the Tunisian population, 
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PDS gene was reported to be associated with sporadic HT (goitrous and non goitrous forms) 
patients. In "Akr" family, there was an absence of linkage between HT and the PDS gene which 
could be explained by the reduced number of patients in the studied sample or by the weak 
contribution of the PDS gene in HT development (Hadj Kacem et al., 2003). 
6.2 Complex segregation analysis 
This kind of analysis aims to foresee whether the genetic susceptibility of complex diseases 
is governed by either a major gene or several minor genes. In AITDs, two previous studies 
have reported evidence for genetic transmission of thyroid peroxidase auto antibodies in old 
order Amish families using the Pointer program (Jaume et al., 1999; Pauls et al., 1993).  
In "Akr" family, we have thought for a long time that segregation of both GD and HT with 
such prevalence could only reflect existence of at least a major gene behind. In order to 
decide between existence and absence of such a component, we have recently performed a 
complex segregation analysis of AITDs in the region harbouring Akr family. Our results 
gave evidence for a polygenic character of these diseases suggesting that genetic 
susceptibility to AITDs results from numerous loci, each contributing with small effects 
rather than a major one (Bougacha-Elleuch et al., 2011). 
7. Conclusion 
Based on “Akr” family studies, it seems that natural history but also the clinical and 
immunological feature of HT disease are not so different between familial and sporadic 
cases. Nevertheless, this multigenerational family remains a particular one with its high 
prevalence of AITDS, its high level of consanguinity and endogamy.  
Regarding the literature, and despite extensive efforts, association studies often failed to 
reach consensus. Many reasons could be advanced for non replication of association studies, 
such as inadequate sample sizes, population stratification, variation in study design, 
confounding sampling bias and misclassification of phenotypes. Concerning HT, besides 
these parameters, there are some difficulties in disease definition. Additionally, co 
segregation of the two clinical forms (HT and GD) in the same family could be considered as 
another element making HT diagnosis more difficult. In such families, genome scan carried 
out tend to reveal chromosomal regions predisposing to AITDs rather than HT. Indeed, this 
approach may identify more easily the common than the specific HT or GD gene 
susceptibility. These observations might advocate setting up separate genome screening 
studies for GD and HT.  
On the other hand, we can also postulate that among important reasons for non replication 
of many linked and/or associated regions/genes is that all these components of AITDs or 
HT "puzzle" contribute with minor effects (as it was evidenced in "Akr" family). 
Consequently, the appropriate approach to detect these small pieces of the puzzle would be 
genome wide association study in large samples. Indeed, as risk factors become more 
common and have smaller effect sizes, GWA studies emerge as a more powerful approach, 
There still is a paucity of GWAS in AITD in general and particularly in HT. A full genome-
wide association analysis solely on AITD has not been published yet.  
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It is clear then, that we have to search for these genes in a large cohort composed only of HT 
patients with restricted clinical criteria to have a homogeneous sample. In this sample, 
investigation will not only be at the genetic level, but also at the transcriptomic one.  
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